Tango Therapeutics, Inc.
TNGX
$25.60
-$0.05-0.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.01B | 379.84M | 343.14M | 152.81M | 180.79M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.68M | 12.49M | 10.19M | 10.54M | 8.89M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 428.00K | 428.00K | 428.00K |
| Total Current Assets | 1.03B | 392.33M | 353.76M | 163.78M | 190.10M |
|
|
|||||
| Total Current Assets | 1.03B | 392.33M | 353.76M | 163.78M | 190.10M |
| Net Property, Plant & Equipment | 39.76M | 41.03M | 42.49M | 43.93M | 45.34M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.45M | 2.43M | 1.94M | 2.43M | 2.45M |
| Total Assets | 1.07B | 435.79M | 398.69M | 210.14M | 237.89M |
|
|
|||||
| Total Accounts Payable | 1.81M | 2.43M | 1.18M | 2.23M | 2.61M |
| Total Accrued Expenses | 12.71M | 7.51M | 16.47M | 11.38M | 9.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.94M | 2.83M | 2.74M | 3.10M | 2.53M |
| Total Finance Division Other Current Liabilities | 2.83M | 1.56M | 1.29M | 1.73M | 25.37M |
| Total Other Current Liabilities | 2.83M | 1.56M | 1.29M | 1.73M | 25.37M |
| Total Current Liabilities | 20.30M | 14.33M | 21.68M | 18.44M | 40.03M |
|
|
|||||
| Total Current Liabilities | 20.30M | 14.33M | 21.68M | 18.44M | 40.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 29.05M | 29.96M | 30.83M | 31.66M | 32.47M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 30.44M |
| Total Liabilities | 49.35M | 44.29M | 52.51M | 50.11M | 102.94M |
|
|
|||||
| Common Stock & APIC | 1.73B | 1.04B | 949.11M | 724.31M | 715.15M |
| Retained Earnings | -704.01M | -648.67M | -603.15M | -564.40M | -580.29M |
| Treasury Stock & Other | -633.00K | -115.00K | 224.00K | 121.00K | 94.00K |
| Total Common Equity | 1.02B | 391.51M | 346.18M | 160.03M | 134.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.02B | 391.51M | 346.18M | 160.03M | 134.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.02B | 391.51M | 346.18M | 160.03M | 134.95M |
|
|
|||||